Gliflozins for the prevention of stroke in diabetes and cardiorenal diseases: A meta-analysis of cardiovascular outcome trials

BACKGROUND: Individual randomized trials are not powered to assess the relationship between use of sodium–glucose transporter 2 inhibitors and risk of stroke. We sought to explore this issue by a meta-analysis incorporating relevant trials including several latest trials. METHODS: Cardiovascular out...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Li-Min, Huang, Jia-Nan, Qiu, Mei, Ding, Liang-Liang, Zhan, Ze-Lin, Ning, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483857/
https://www.ncbi.nlm.nih.gov/pubmed/34596148
http://dx.doi.org/10.1097/MD.0000000000027362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483857/
https://www.ncbi.nlm.nih.gov/pubmed/34596148
http://dx.doi.org/10.1097/MD.0000000000027362

Ejemplares similares